155 related articles for article (PubMed ID: 8522468)
21. The bioavailability of nasogastric versus tablet-form oral trovafloxacin in healthy subjects.
Vincent J; Teng R; Pelletier SM; Willavize SA; Friedman HL
Am J Surg; 1998 Dec; 176(6A Suppl):23S-26S. PubMed ID: 9935253
[TBL] [Abstract][Full Text] [Related]
22. Levofloxacin and trovafloxacin: the next generation of fluoroquinolones?
Ernst ME; Ernst EJ; Klepser ME
Am J Health Syst Pharm; 1997 Nov; 54(22):2569-84. PubMed ID: 9397218
[TBL] [Abstract][Full Text] [Related]
23. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.
Chien SC; Wong FA; Fowler CL; Callery-D'Amico SV; Williams RR; Nayak R; Chow AT
Antimicrob Agents Chemother; 1998 Apr; 42(4):885-8. PubMed ID: 9559801
[TBL] [Abstract][Full Text] [Related]
24. An open, controlled, crossover study on the effects of cimetidine on the steady-state pharmacokinetics of trovafloxacin.
Purkins L; Oliver SD; Willavize SA
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):431-3. PubMed ID: 9758288
[TBL] [Abstract][Full Text] [Related]
25. Trovafloxacin: an overview.
Garey KW; Amsden GW
Pharmacotherapy; 1999 Jan; 19(1):21-34. PubMed ID: 9917076
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of [18F]trovafloxacin in healthy human subjects studied with positron emission tomography.
Fischman AJ; Babich JW; Bonab AA; Alpert NM; Vincent J; Callahan RJ; Correia JA; Rubin RH
Antimicrob Agents Chemother; 1998 Aug; 42(8):2048-54. PubMed ID: 9687405
[TBL] [Abstract][Full Text] [Related]
27. Safety, tolerability and pharmacokinetics of the new long-acting quinolone DW-116 after single and multiple dosing in healthy subjects.
Meyerhoff C; Dilger C; Yoon SJ; Chung YH; Lee DK; Lee CW; Ryu JM; Choi MS; Pabst G; Reh C
J Antimicrob Chemother; 1998 Sep; 42(3):349-61. PubMed ID: 9786475
[TBL] [Abstract][Full Text] [Related]
28. Oral bioavailability and pharmacokinetics of trovafloxacin in patients with AIDS.
Lacy MK; Nicolau DP; Nightingale CH; Geffken A; Teng R; Vincent J; Quintiliani R
Antimicrob Agents Chemother; 1999 Dec; 43(12):3005-7. PubMed ID: 10582898
[TBL] [Abstract][Full Text] [Related]
29. Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin.
Cutler NR; Vincent J; Jhee SS; Teng R; Wardle T; Lucas G; Dogolo LC; Sramek JJ
Antimicrob Agents Chemother; 1997 Jun; 41(6):1298-300. PubMed ID: 9174187
[TBL] [Abstract][Full Text] [Related]
30. Pharmacodynamics of trovafloxacin in experimental pneumococcal meningitis: basis for dosage selection in children with meningitis.
McCoig CC; Wubbel L; Jafri HS; Lutsar I; Bastero R; Olsen K; Shelton S; Friedland IR; McCracken GH
J Antimicrob Chemother; 1999 May; 43(5):683-8. PubMed ID: 10382890
[TBL] [Abstract][Full Text] [Related]
31. Concentrations of trovafloxacin in colonic tissue and peritoneal fluid after intravenous infusion of the prodrug alatrofloxacin in patients undergoing colorectal surgery.
Melnik G; Schwesinger WH; Dogolo LC; Teng R; Vincent J
Am J Surg; 1998 Dec; 176(6A Suppl):14S-17S. PubMed ID: 9935251
[TBL] [Abstract][Full Text] [Related]
32. A comparison of the photosensitizing potential of trovafloxacin with that of other quinolones in healthy subjects.
Ferguson J; McEwen J; Al-Ajmi H; Purkins L; Colman PJ; Willavize SA
J Antimicrob Chemother; 2000 Apr; 45(4):503-9. PubMed ID: 10747828
[TBL] [Abstract][Full Text] [Related]
33. Effect of omeprazole on the pharmacokinetics of oral gemifloxacin in healthy volunteers.
Allen A; Vousden M; Lewis A
Chemotherapy; 1999; 45(6):496-503. PubMed ID: 10567781
[TBL] [Abstract][Full Text] [Related]
34. Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague-Dawley rats and beagle dogs. Effect of bile duct cannulation on excretion pathways.
Dalvie DK; Khosla NB; Navetta KA; Brighty KE
Drug Metab Dispos; 1996 Nov; 24(11):1231-40. PubMed ID: 8937858
[TBL] [Abstract][Full Text] [Related]
35. Randomized trial of trovafloxacin and ofloxacin for single-dose therapy of gonorrhea. Trovafloxacin Gonorrhea Study Group.
Jones RB; Schwebke J; Thorpe EM; Dalu ZA; Leone P; Johnson RB
Am J Med; 1998 Jan; 104(1):28-32. PubMed ID: 9528716
[TBL] [Abstract][Full Text] [Related]
36. Trovafloxacin.
Haria M; Lamb HM
Drugs; 1997 Sep; 54(3):435-45; discussion 446. PubMed ID: 9279505
[TBL] [Abstract][Full Text] [Related]
37. Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: phase I study.
García-Calvo G; Parra A; Aguilar L; Ponte C; Giménez MJ; Carcas A; Kinzig-Schippers M; Soriano F
Antimicrob Agents Chemother; 2001 Jun; 45(6):1876-8. PubMed ID: 11353641
[TBL] [Abstract][Full Text] [Related]
38. A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers.
van Nispen CH; Hoepelman AI; Rozenberg-Arska M; Verhoef J; Purkins L; Willavize SA
Am J Surg; 1998 Dec; 176(6A Suppl):27S-31S. PubMed ID: 9935254
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and tolerance of a new fluoroquinolone antimicrobial drug after single oral doses in healthy volunteers.
Tanaka M; Tamura K; Atarashi S; Kubo Y; Oliver SD; Bentley M; Hakusui H
Xenobiotica; 1995 Nov; 25(10):1119-25. PubMed ID: 8578768
[TBL] [Abstract][Full Text] [Related]
40. Serum bactericidal activity of trovafloxacin, in combination with cefepime or amikacin, in healthy volunteers.
Lubasch A; Ziege S; Brodersen B; Borner K; Koeppe P; Lode H
Clin Microbiol Infect; 2003 Jul; 9(7):670-7. PubMed ID: 12925107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
